Code of Ethics
for Pharmaceutical Marketing
is aimed at ensuring the transparency and compliance
of the activities of pharmaceutical companies operating in Lithuania
with the principles of professional ethics.
The Code of Ethics for Pharmaceutical Marketing has been adopted at the will and upon common agreement of IFPA and VGA – associations of companies engaged in pharmaceutical marketing in Lithuania.
Code of Ethics for Pharmaceutical Marketing
Has been adopted
at the will and upon common agreement of IFPA and VGA.
Code seeks to
ensure that pharmaceutical companies engage in an ethical promotion, restrain from deceitful practices and potential conflicts of interest with healthcare professionals, and comply with applicable laws and regulations.
It is applied
to companies engaged in pharmaceutical marketing in Lithuania.
Thus the Code seeks to enable an environment where the general public may be sure that the choices regarding their medicinal products are made based on the merit of each product and the patients’ clinical needs. This Code does not aim at restraining the promotion of medicines in such a way as to hinder fair competition or limit interaction with healthcare professionals. Guided by the mission of EFPIA and common goals with IFPA and VGA, other parties, not belonging to IFPA and VGA, can also join the Code.